The groundbreaking rise of Viagra has firmly established as a example of pharmaceutical success, but its legacy within the broader sector now presents questions about future yields . Copycat versions are diminishing patent protection , leading to concerns that betting on companies heavily reliant to Viagra's once-dominant standing could be a specul